Discover
PBYI
Puma Biotechnology, Inc.
7.99
2 x 5.82
2 x 10.09
bid
ask
-
0.12
1.48%
2 @ 04:00 PM
7.99 +0.00 (0.00%)
| Ytd | 34.29% | |
| 1y | 122.56% |
7.86
day range
8.16
3.03
52 week range
8.41
| Open | 8.07 | Prev Close | 8.11 | Low | 7.86 | High | 8.16 | Mkt Cap | 406.69M |
| Vol | 224.37K | Avg Vol | 287.74K | EPS | 0.48 | P/E | 16.65 | Forward P/E | 11.71 |
| Beta | 1.08 | Short Ratio | 5.09 | Inst. Own | 67.74% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 7.33 | 200-d Avg | 6.26 | 1yr Est | 4.33 |
| Income Statement | |||
| Total Revenue | 44.81M | ||
| Revenues (USD) | 44.81M | ||
| Cost of Revenue | 10.42M | ||
| Gross Profit | 34.39M | ||
| Operating Expenses | 38.22M | ||
| Research and Development Expense | 19.80M | ||
| Selling, General and Administrative Expense | 18.42M | ||
| Operating Income | -3.83M | ||
| Interest Expense | 731.00K | ||
| Income Tax Expense | 326.00K | ||
| Net Income | -3.75M | ||
| Net Income Common Stock | -3.75M | ||
| Net Income Common Stock (USD) | -3.75M | ||
| Consolidated Income | -3.75M | ||
| Earnings per Basic Share | -0.07 | ||
| Earnings per Basic Share (USD) | -0.07 | ||
| Earnings per Diluted Share | -0.07 | ||
| Earning Before Interest & Taxes (EBIT) | -2.70M | ||
| Earning Before Interest & Taxes (USD) | -2.70M | ||
| Weighted Average Shares | 50.85M | ||
| Weighted Average Shares Diluted | 50.85M | ||
| Balance Sheet | |||
| Cash and Equivalents | 38.28M | ||
| Cash and Equivalents (USD) | 38.28M | ||
| Investments | 65.35M | ||
| Investments Current | 65.35M | ||
| Trade and Non-Trade Receivables | 26.33M | ||
| Current Assets | 142.26M | ||
| Property, Plant & Equipment Net | 4.70M | ||
| Total Assets | 192.70M | ||
| Debt Current | 11.41M | ||
| Total Debt | 15.95M | ||
| Current Liabilities | 59.74M | ||
| Debt Non-Current | 4.55M | ||
| Total Liabilities | 64.28M | ||
| Accumulated Retained Earnings (Deficit) | -1.29B | ||
| Accumulated Other Comprehensive Income | -31.00K | ||
| Shareholders Equity | 128.42M | ||
| Shareholders Equity (USD) | 128.42M | ||
| Assets Non-Current | 50.44M | ||
| Total Debt (USD) | 15.95M | ||
| Goodwill and Intangible Assets | 38.96M | ||
| Inventory | 8.69M | ||
| Liabilities Non-Current | 4.55M | ||
| Trade and Non-Trade Payables | 8.17M | ||
| Tax Assets | 3.83M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.58M | ||
| Net Cash Flow from Financing | -11.33M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.56M | ||
| Issuance (Repayment) of Debt Securities | -11.11M | ||
| Net Cash Flow from Investing | 2.47M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.47M | ||
| Net Cash Flow from Operations | 15.42M | ||
| Share Based Compensation | 1.90M | ||